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Nitric oxide synthase inhibitorMitochondria generated nitric oxide (NO•) regulates several cell functions including energy metabolism, cell
cycling, and cell death. Here we report that the NO• synthase inhibitors (L-NAME, L-NNA and L-NMMA)
administered either in vitro or in vivo induce Ca2+-dependent mitochondrial permeability transition (MPT)
in rat liver mitochondria via a mechanism independent on changes in the energy state of the organelle. MPT
was determined by the occurrence of cyclosporin A sensitive mitochondrial membrane potential disruption
followed by mitochondrial swelling and Ca2+ release. In in vitro experiments, the effect of NOS inhibitors was
dose-dependent (1 to 50 µM). In addition to cyclosporin A, L-NAME-induced MPT was sensitive to Mg2+ plus
ATP, EGTA, and to a lower degree, to catalase and dithiothreitol. In contrast to L-NAME, its isomer D-NAME
did not induce MPT. L-NAME-induced MPT was associated with a signiﬁcant decrease in both the rate of NO•
generation and the content of mitochondrial S-nitrosothiol. Acute and chronic in vivo treatment with L-
NAME also promoted MPT and decreased the content of mitochondrial S-nitrosothiol. SNAP (a NO• donor)
prevented L-NAME mediated MPT and reversed the decrease in the rate of NO• generation and in the
content of S-nitrosothiol. We propose that S-nitrosylation of critical membrane protein thiols by NO•
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Nitric oxide (NO•) is an ubiquitous intra and inter-cellular
messenger involved in the regulation of diverse physiological pro-
cesses, such as neurotransmission, vasodilation, immune response
and cell cycling and arrest [1,2]. On the other hand, at elevated con-
centrations, NO• can also be cytotoxic [3,4]. The synthesis of NO• from
L-arginine and O2 is catalyzed by nitric oxide synthases (NOS). Up to
the early 90s, three distinct isoforms of NOS had been well char-
acterized, two constitutive (endothelial, eNOS, and neuronal, nNOS)
and one inducible (iNOS). They require several co-factors, includingFAD, FMN, BH4, Ca2+ and NADPH. All NOS isoforms require Ca2+ for
their activity, although iNOS is signiﬁcantly less dependent on Ca2+
than the other isoforms [5].
The existence of a mitochondrial NO• synthase (mtNOS) was ﬁrst
suggested by immunohistochemical studies that found that anti-NOS
antibodies stained mitochondria [6–8]. Next, biochemical properties
of mtNOS were characterized in puriﬁed liver mitochondria [9–11].
The activity of mtNOS was also determined in mitochondria puriﬁed
from different tissues of rats and mice, including brain, heart, kidney,
thymus and skeletal muscle (for a review see [12]). The identity of a
liver mtNOS was described by Elfering et al. [13]. They sequenced
mtNOS, identiﬁed the protein as a splice variant of the nNOS, and
localized it in the inner mitochondrial membrane. In support for this
ﬁnding, a previous work described the lack of mtNOS in the heart of
nNOS knockout mice [14]. More recent evidences suggest that mtNOS
is structurally linked to both complexes I and IV [15,16]. Nonetheless,
a considerable debate about the molecular identity of the mtNOS
persists [17–20]. Additionally, NO• can be produced inside mitochon-
dria by other NOS independent pathways [21–23].
The mitochondria generated NO• regulates O2 consumption,
energy metabolism, and reactive oxygen species (ROS) formation
(for a review see [24]). Mitochondria also generate the anion super-
oxide (O2•−). Although these two radical species are not toxic at
physiological concentrations, an imbalance in their production or
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isms regulating cell life. The reaction of these two species generates
peroxynitrite (ONOO−), a potent oxidant that react with most
biological molecules causing cell damage. In addition to peroxynitrite,
other reactive nitrogen species [6] are derived from NO•, including
nitroxyl (HNO), nitrosonium cation (NO+) and S-nitrosothiols
(RSNOs), [25–29].
NO• reversibly interacts with cytochrome oxidase modulating
mitochondria respiration rate [2,30]. In addition, the interaction
of NO• with thiol groups forming S-nitrosothiols in mitochondria
may be of physiological importance [31]. The formation of protein
S-nitrosothiols may enable the reversible regulation of protein
function [32]. The biological role of S-nitrosylation is also related to
the protection of protein thiols under oxidative stress conditions,
as it will be discussed ahead.
Mitochondrial protein oxidation, lipid peroxidation and DNA
damage caused by ROS and RNS have been extensively documented
(reviewed in [28,33,34]). The inner membrane proteins are primary
targets for oxidative damage, a process that is activated by excessive
matrix Ca2+. Oxidation of membrane protein thiols induces the for-
mation of the permeability transition pore (PTP) via protein aggre-
gation due to dithiol formation [35]. We have proposed that these
protein aggregates form aqueous channels that confer non-selective
permeabilization of the inner mitochondrial membrane [36]. A large
body of evidences indicates that mitochondrial permeability transi-
tion is involved in cell death mechanisms determining whether the
fate of cells will be apoptosis or necrosis [37]. It seems to operate as an
ATP switch by establishing the balance between ATP availability and
ATP hydrolysis after PTP opening [38].
It is well known that NO• has pro- and anti-apoptotic effects
depending on its concentration range. At high production rates
(N2 µM/s), NO• induces MPT via a Ca2+-dependent mechanism,
probably due to the formation of ONOO−. This RNS reacts with thiols
by one or two electron oxidations to produce thiyl radicals (RS•) and
sulfenic acids (RSOH), respectively, both of which usually react with
protein thiols to form disulﬁdes or other forms of higher thiol oxi-
dation [31]. In contrast, at low levels, NO• may inhibit MPT (IC50 of
11 nM NO•/s) [39].
The objective of the present study was to investigate the rela-
tionship between mitochondria generated NO• and MPT using non-
selective NOS inhibitors under experimental conditions of fully pre-
served mitochondrial respiration. We tested the hypothesis that NO•
protects against MPT via S-nitrosylation of critical mitochondrial
membrane protein thiol groups.
2. Materials and methods
2.1. Isolation of liver mitochondria
Liver mitochondria from adult rats fasted overnight were isolated
by conventional differential centrifugation [40] and partially puriﬁed
by a discontinuous Percoll gradient. Brieﬂy, livers were homogenized
in 250 mM sucrose, 1 mM EGTA, and 10 mM Hepes buffer (pH 7.2),
and centrifuged for 10 min at 2500 rpm. The supernatant was
centrifuged for 10 min at 8000 rpm. The mitochondrial pellet was
puriﬁed using a discontinuous Percoll gradient according to [41]. The
mitochondrial fraction obtained from the interface between 19 and
52% Percoll layers was washed in medium containing 250 mM
sucrose, 10 mM Hepes and 0.1 mM EGTA, for 10 min at 8000 rpm.
The ﬁnal pellet was resuspended in 250 mM sucrose and 10 mM
Hepes to a ﬁnal protein concentration of 80–100 mg/ml.
2.2. Standard incubation procedure
The experiments were carried out at 28 °C, with continuous
magnetic stirring, in standard medium containing 125 mM sucrose,65 mM KCl, 2 mM inorganic phosphate, 1 mM magnesium chloride,
10 mMHepes buffer (pH 7.2) and a complex I substratemixture made
of malate, pyruvate, ketoglutarate and glutamate (5 mM each). Other
additions are indicated in the ﬁgure legends.
2.3. Animals and L-NAME treatment
Female Wistar rats (180–250 g) had free access to standard
laboratory rodent chow diet (Nuvital CR1, PR, Brazil) and water
and were housed at 22±2 °C on a 12 h light–dark cycle. L-NAME
(50 mg/kg i.p.) or saline was given once i.p., and after 14 h, rats were
killed by cervical dislocation, livers were perfused with cold saline
solution and excised for mitochondria isolation. Some rats were also
subject to a chronic treatment with L-NAME added to their drinking-
water (1 mg kg−1 day−1) during 14 days.
2.4. Mitochondrial swelling
Mitochondrial swelling (0.5 mg/ml) was determined as the
decrease in the turbidity of the mitochondrial suspension measured
at 520 nm using a temperature-controlled Hitachi U-3000 spectro-
photometer (28 °C).
2.5. Mitochondrial membrane potential disruption
Mitochondria (0.5 mg/ml) were incubated in the standard
reaction medium containing 2 µM tetraphenylphosphonium (TPP+)
at 28 °C. The concentration of TPP+ in the extramitochondrial
mediumwas continuously monitored with a TPP+-selective electrode
prepared in our laboratory according to [42]. The membrane potential
was then calculated by assuming that the TPP+ distribution between
mitochondria and the medium follows the Nernst equation. Correc-
tions due to the binding of TPP+ to themitochondrial membranewere
made according to Jensen et al. [43]. No corrections were made to
compensate Δψ values for the continuous alteration in mitochondrial
volume that occurs during the experiments.
2.6. Mitochondrial calcium transport
Calcium uptake and release by isolated liver mitochondria (0.5 mg/
ml) was determined following the ﬂuorescence of 0.1 µM Calcium
Green-5N hexapotassium salt (Molecular Probes) using a tempera-
ture-controlled Hitachi F4500 spectroﬂuorometer (28 °C) at excita-
tion and emission wavelengths of 506 and 531 nm, respectively, and
slit widths of 5.0 nm [44].
2.7. Mitochondrial nitric oxide production
The probe DAF-FM (10 µM) was used to monitor NO• release from
rat liver mitochondria (0.5 mg/ml) using a temperature-controlled
Hitachi F4500 spectroﬂuorometer (28 °C) at excitation and emission
wavelengths of 495 and 515 nm, respectively, and slit widths of
2.5 nm. Superoxide dismutase (1 µM) and catalase (1 µM) were
added to prevent interference of O2•− and H2O2. To test DAF spec-
iﬁcity to NO• under our experimental conditions we added the NO•
donor SNAP at different concentrations, and observed a rapid and
proportional increase in the probe ﬂuorescence. The calibration was
made using DAF-2T the product of the reaction between DAF-FM and
NO•.
2.8. Mitochondrial S-nitrosothiol determination
The samples were prepared according to [3]. Mitochondria
were disrupted by shaking with 0.5% Triton X-100 for 60 min at 4 °C
and insoluble proteins were removed by centrifugation at 20,000 g
for 60 min. The supernatant was used to determine S-nitrosothiol
Fig. 1. Mitochondrial swelling induced by NOS inhibitors in vitro (A) and dose-
dependent effect of L-NAME on mitochondrial swelling (B) and on mitochon-
drial membrane potential (Δψ) disruption (C). Panel A: Rat liver mitochondria (RLM,
0.5 mg/ml) were incubated in the standard medium containing 30 µM Ca2+ in the
presence of 50 µM of L-NAME, L-NMMA, L-NNA, or D-NAME. Absorbances at 7 min were:
1.270±0.062 (Control), 1.253±0.093 (D-NAME), 0.955±0.075 (L-NAME), 0.958±
0.037 (L-NNA), and 0.966±0.186 (L-NMMA), pb0.001 for control and D-NAME vs. all
NOS inhibitors. Panel B: L-NAME was present at indicated concentrations. Ab-
sorbances at 7 min were: 1.465±0.104 (Control), 1.368±0.196 (1 µM L-NAME),
1.175±0.172 (10 µM L-NAME), 1.145±0.167 (25 µM L-NAME), and 0.948±0.023
(50 µM L-NAME), pb0.05 for control vs. 10, 25 and 50 µM L-NAME. Panel C: Standard
medium containing 2 µM TPP+, 25 µM Ca2+ and L-NAME at indicated concen-
trations. Average time of Δψmaintenance was: 24.9±2.8 (Control), 18.6±1.5 (1 µM
L-NAME), 16.3±7.3 (10 µM L-NAME), 14.8±3.0 (25 µM L-NAME) and 12.7±1.9
(50 µM L-NAME), pb0.05 for control vs. 10, 25 and 50 µM L-NAME. Lines are repre-
sentative of ﬁve independent experiments.
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incubated with 300 µM 2,3-diaminonaphthalene (DAN) diluted in
HCl (0.5 M). HgCl2 was used to release NO• during a 10 min incubation
in the dark. After this, samples were alkalinized with NaOH (1 M)
and incubated for an additional 10 min period in the dark. Then,
ﬂuorescence was followed in a temperature-controlled Hitachi F4500
spectroﬂuorometer (28 °C) at excitation and emission wavelengths of
381 and 407 nm, respectively, and slit widths of 2.5 nm (excitation)
and 5.0 nm (emission). Nitrosothiol content was calculated using a
standard curve generated with NaNO2.
2.9. Statistical analyses
Data from the experiments were analyzed by one-way ANOVA,
followed by a post hoc Tukey test, using OriginLab 7.5 software
(OriginLab Corp.). Student t-test was used for twomean comparisons.
The data are presented as averages±SD of at least four experiments
conducted with different preparations.
2.10. Chemicals
L-NAME, D-NAME, L-NNA, L-NMMA, SNAP, Cyclosporin A, catalase,
SOD, EGTA, FCCP, NEM, HgCl2, 2,3-Diaminonaphthalene (DAN),
and NaNO2 were purchased from Sigma (St. Louis, USA). Cal-
cium green-5N and DAF-FM were purchased from Molecular Probes.
DAF-2T was obtained from Alexis Biochemicals. All other reagents
were products of the highest purity grade available.
3. Results
The effects of NOS inhibitors on mitochondrial swelling and
membrane potential are shown in Fig. 1. The experiments depicted in
Fig. 1A show that L-NAME, L-NNA and L-NMMA (50 µM each), in
contrast to the L-NAME isomer D-NAME, induced extensive swelling
of mitochondria suspended in the incubation medium containing
30 µM Ca2+. The effect of L-NAME was dose-dependent (1–50 µM)
both on mitochondrial swelling (Fig. 1B) and on the disruption of
membrane potential (Fig. 1C).
The mechanisms by which L-NAME induced the loss of mitochon-
drial integrity in vitrowere additionally investigated. Fig. 2 shows that
the effects of L-NAME on mitochondrial swelling (panel A) and mem-
brane potential disruption (panel B) were inhibited, totally or par-
tially, by the MPT inhibitors CsA, Mg2+ plus ATP, catalase, and DTT, a
disulﬁde reductant.
Since MPT is stimulated by Ca2+ accumulation and the inhibitory
effects of NO• on MPT could be secondary to inhibition of Ca2+ uptake
by the organelle [39], we examined the effect of L-NAME on mito-
chondrial Ca2+ handling, under our experimental conditions (Fig. 2C).
The data show that initially the mitochondrial Ca2+ inﬂux was unaf-
fected by the presence of L-NAME. However, after a Ca2+ pulse, the
capacity to retain Ca2+ was decreased by L-NAME, via a mechanism
sensitive to cyclosporin A. The results indicate that L-NAME, as well as
the other NOS inhibitors, the arginine analogues L-NNA and L-NMMA,
has the ability to act as a MPT inducer independently of changes in the
capacity of mitochondrial Ca2+ accumulation and respiration (data
not shown).
To investigate whether a NO• donor could prevent the effect of
L-NAME on MPT, we performed experiments in the presence of
SNAP (Fig. 3). Interestingly, Fig. 3A shows that SNAP, at the con-
centration of 10 nM, retards both the swelling induced by Ca2+
alone and that induced by Ca2+ plus L-NAME. The presence of
10 nM SNAP did not affect Ca2+ inﬂux to mitochondria but, in
agreement with the experiment of Fig. 3A, retards Ca2+ release in
the presence or absence of L-NAME (Fig. 3B). These results suggest
that neither L-NAME nor 10 nM SNAP have a direct effect on mito-
chondrial permeabilization and that the observed effects are cer-tainly mediated by NO•, in a concentration range that does not
affect either Ca2+ inﬂux or respiration (not shown).
In order to further characterize the role of endogenous NO• on
MPT, we performed experiments analyzing the effect of L-NAME on
NO• generation by mitochondria (Fig. 4). The experiments started by
the addition of mitochondria to the standard medium containing
10 µM of the NO• probe, DAF-AM (Fig. 4A). A biphasic increase in DAF
ﬂuorescence was observed: an initial phase with higher slope was
followed by a second phase with lower slope that begun 3–4 min after
Fig. 2. Inhibition of L-NAME-induced mitochondrial swelling (A), membrane potential
disruption (B) and calcium release (C) by MPT inhibitors. Rat liver mitochondria (RLM,
0.5 mg/ml) were incubated in the standard medium with 50 µM L-NAME and 30 µM
Ca2+ in the presence of the MPT inhibitors: cyclosporin A (CsA, 1 µM), ATP (200 µM)
plus Mg2+ (5 mM), catalase (2 µM), or dithiothreitol (DTT, 500 µM). Panel A: Ab-
sorbances at 7 min were: 1.332±0.138 (Control), 1.395±0.172 (CsA), 1.387±0.137
(ATP+Mg2+), 1.020±0.047 (DTT), and 0.980+0.043 (L-NAME), pb0.05 for L-NAME vs.
control, CsA, andATP+Mg2+. Panel B:Average timeofΔψ retention (min)was: 24.0±5.4
(Control), 18.8±3.5 (DTT), 20.8±1.8 (Catalase) and 14.9±3.6 (L-NAME), pb0.05 for
L-NAME vs. control, CsA, and ATP+Mg2+. Panel C: Average time of calcium release
(min) was: 7.1±0.6 (Control) and 2.8±1.0 (L-NAME), pb0.05. Lines are represen-
tative of ﬁve independent experiments.
Fig. 3. SNAP protects against L-NAME-induced mitochondrial swelling (A) and
calcium release (B). Rat liver mitochondria (RLM, 0.5 mg/ml) were incubated in
standard medium containing 30 µM Ca2+ in the presence or absence of SNAP (10 nM)
and L-NAME (50 µM) as indicated. Panel A: Absorbances at 7 min were: 1.327±0.066
(SNAP), 1.295±0.118 (Control), 1.250±0.144 (L-NAME+SNAP) and 1.040±0.121
(L-NAME), pb0.05 for L-NAME vs. all others. Panel B: Average calcium retention time
(min) was: 8.7±0.9 (SNAP), 7.2±0.5 (Control), 6.1±2.0 (L-NAME+SNAP), and 2.9±
0.9 (L-NAME), pb0.05 for L-NAME vs. all others. Lines are representative of ﬁve
independent experiments.
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may reﬂect the reaction of DAF with a pre-formed mitochondrial pool
of NO• and the second slower phase of ﬂuorescence increase probably
represents the steady state rate of NO• generation by mitochondria.
This second phase was considered for the estimations of mitochon-
drial NO• generation rates. According to our standard curve built
using DAF-2T, the rates of NO• generation were 0.35 pmol NO•/mg
under the control conditions and 0.18 pmol NO•/mg in the presence
of L-NAME (Fig. 4B). Therefore, 50 µM L-NAME caused an inhibition
of 47% in the mitochondria generation rate of NO•. Furthermore,
an experiment using D-NAME, instead of L-NAME, did not show any
difference in the rate of DAF ﬂuorescence as compared to the control
(Fig. 4B). Additions of increasing concentrations of the NO• donor
SNAP were done to the preparations containing L-NAME andsigniﬁcantly increased the slope of DAF ﬂuorescence (Fig. 4A and B).
No mitochondrial swelling was detected under these experimental
conditions (low Ca2+ concentration) (data not shown).
Since NO• promotes S-nitrosylation of cysteine residues in
mitochondrial membrane proteins [4] we analyzed the inﬂuence of
L-NAME on the content of mitochondrial S-nitrosothiol. Fig. 5 shows
that L-NAME decreases S-nitrosothiol content by 36% when compared
to the control. On the other hand, 10 nM SNAP totally abrogates the
effect of L-NAME. In order to eliminate the possible interference of
mitochondrial swelling in S-nitrosothiol estimation, we performed a
control experiment in the presence of alamethicin, a non-selective
inducer of mitochondrial membrane permeabilization. This com-
pound did not cause any change in S-nitrosothiol content when
compared to the control (Fig. 5), despite the extensive swelling it
induces. The higher content of S-nitrosothiol found in our determina-
tions in relation to literature data [30,46,47] is probably due to the fact
that our assaywas done inwholemitochondria, which presents a high
content of matrix S-nitrosylated glutathione content [48].
The effect of L-NAME was also tested in vivo, using two treatment
protocols that inhibit all isoforms of NOS in animal tissues. The ex-
periments presented in Fig. 6A show that liver mitochondria isolated
from rats 14 h after an acute dose of L-NAME (50 mg/kg i.p.) are more
susceptible to MPT than those isolated from control animals. Under
these experimental conditions, mitochondrial swelling was also pre-
vented by theMPT inhibitors, CsA, ATP plusMg2+ or catalase (Fig. 6B).
More important, in vivo L-NAME treatment decreased mitochondrial
Fig. 4. Inhibition of mitochondrial NO• generation by L-NAME. NO• production by
mitochondria (0.5 mg/ml) was measured using 10 µM DAF-FM in the presence of 1 µM
SOD and 1 µM catalase. Standard medium contained 10 µM Ca2+. Panel A: Represen-
tative experiment of mitochondrial NO• production in the presence of D-NAME (50 µM)
or L-NAME (50 µM), with addition of SNAP (10 nM or 1 µM) as indicated. Panel B:
Quantiﬁcation of total NO• generated (pmol/mg mitochondrial protein/min). *pb0.05
for L-NAME and SNAP (1 µM) vs. control. Results represent six independent
experiments.
Fig. 6. In vivo treatment with L-NAME promotes Ca2+ induced mitochondrial swelling
(A) sensitive to MPT inhibitors (B). Rat liver mitochondria (RLM, 0.5 mg/ml)
from control and L-NAME treated rats were incubated in the presence of 30 µM Ca2+.
Panel A: Absorbances for swelling at 7 min were: 1.300±0.105 (Control) vs. 1.042±
0.187 (L-NAME), pb0.05. Panel B: RLM from L-NAME treated rats were incubated in
the presence of MPT inhibitors cyclosporin A (CsA, 1 µM), ATP (200 µM)+Mg2+
(5 mM) and catalase (2 µM). Absorbances at 7 min were: 1.396±0.029 (CsA), 1.324±
0.024 (ATP+Mg2+), 1.156±0.104 (Catalase), and 1.062±0.173 (L-NAME), pb0.05 for
L-NAME vs. MPT inhibitors. Lines are representative of ﬁve independent experiments.
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Similar results were obtained when the rats were chronically treated
with L-NAME added to their drinking-water (1 mg kg−1 day−1
during 14 days; results not shown).Fig. 5. SNAP protects against L-NAME-induced decrease in the content of mitochondrial
S-nitrosothiol. Assay was performed in mitochondria (0.5 mg/ml) samples after a
10 min incubation in the presence of 30 µM Ca2+ and 50 µM L-NAME, 10 nM SNAP or L-
NAME plus SNAP as indicated. Alamethicin (Alam, 5 µg/ml) plus EGTA (200 µM), a
calcium independent mitochondria swelling inducer, was used to show no interference
of mitochondrial swelling on the nitrosothiol quantiﬁcation. *pb0.05 for L-NAME vs. all
others. Data are averages±SD (n=8). Lines are representative of eight independent
experiments.4. Discussion
The ﬁrst evidences that mitochondria generate NO• and possess
their ownmtNOS were published more than 10 years ago [9–11]. Due
to the enormous physiological relevance of NO•, the issue attracted
great interest among researchers in the area and generated a large
controversy. This subject has been critically analyzed in several recentFig. 7. In vivo treatment with L-NAME decreased the content of mitochondrial S-
nitrosothiol. Assay was performed in mitochondria (0.5 mg/ml) samples after a 10 min
incubation in the presence of 30 µM Ca2+, data are averages±SD (n=5). *pb0.05.
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not a ﬁnal proof, they support the existence of such a mtNOS since
they provide evidence that the lack of mitochondrially generated NO•
impairs the mitochondrial resistance to Ca2+-dependent MPT. The
previous demonstrations that Ca2+ induced MPT is sensitive to
catalase and thiol reagents (mainly DTT) indicated that MPT is favored
by accumulation of H2O2 and triggered by oxidation of membrane
protein thiols [35,36,50,51]. The stimulation of MPT by NOS inhibitors,
in vitro and in vivo, and conversely the protection against MPT con-
ferred by the NO• donor SNAP in fully functioning mitochondria,
are strong evidences of a new relevant physiological role of mtNOS, as
opposed to others' claims [19].
In this study, the role of NO• on the MPT susceptibility was
approached by using low concentrations of either NOS inhibitors or
the NO• donor SNAP, which effectively modiﬁed the rates of NO•
generation in the organelle. All non-selective NOS inhibitors used
here, named L-NAME, L-NNA and L-NMMA showed the ability to
induce Ca2+-dependent MPT by a dose-dependent mechanism
antagonized by the NO• donor SNAP, in a process independent on
changes of mitochondrial respiration rates and Ca2+ uptake. The
effect of SNAP and lack of effect by D-NAME support the idea that
these NOS inhibitors had no direct effect on MPT per se, but rather
acted via changes in NO• availability in the organelle. Indeed, 50 µM
L-NAME inhibited the rate of NO• generation by about 50% and this
was totally reversed by 1 µM SNAP. The ability of these NOS inhi-
bitors to promote MPT was also documented in mitochondria
isolated from perfused livers of rats treated with L-NAME, either
acutely or chronically. In addition, the lack of effect by D-NAME
conﬁrms the concept that all types of NOS are enantiomer speciﬁc for
their amino acid substrate [52].
It is well established that NO• can have dual effects on mito-
chondrial functions. At physiological concentrations, it regulates some
pathways such as metabolic rate [30,53], mitochondrial biogenesis
[54,55], resistance to MPT [31,38,56] and cell death [57]. Recent
work on mitochondria-target NO• donors shows protection during
ischemia/reperfusion injury in the heart [30]. In contrast, high con-
centrations of NO• generate RNS and lead to pore opening [58], modify
protein function, mainly through nitration of tyrosine residues [59,60]
and impair lipid function also via nitration [59].
Concerning the mechanism of protection against MPT it is worth to
consider that: ﬁrst, many biological effects of NO• are mediated through
S-nitrosylationof protein cysteine thiol and thatmitochondriahavebeen
identiﬁed as organelles with high activity of reversible S-nitrosylation
reactions [46]; second, PTP opening is mediated by membrane protein
polymerization via dithiol formation [35,36]. In this regard,we observed
that NOS inhibitors, under the experimental conditions that induced
MPT, signiﬁcantly decreased both the rate of NO• generation and the
content ofmitochondrial S-nitrosothiol. In contrast, SNAP that protected
against MPT, recovered the rate of NO• generation and the content of S-
nitrosothiols. Therefore, it is conceivable to propose that S-nitrosylation
protects against MPT by competing for critical protein thiols and
blocking the formation of dithiols. This putative role for NO• and S-
nitrosothiols in the protection against MPT is in agreement with data
showing that protein S-nitrosothiols can be generated by pre-formed S-
nitrosothiols that persist mainly when the mitochondrial glutathione
pool is oxidized [31,47], a condition that favors MPT [36]. This suggests
that the reversible S-nitrosylation in mitochondria is related to the
protection of protein thiols against the attack of reactive oxygen when
the antioxidant mitochondrial system, mainly represented by NADPH
and GSH, is deﬁcient, a new biological role of mitochondrially generated
NO•.
In summary, we have identiﬁed that NOS inhibitors induce
MPT through the decrease of both mitochondrial generation of NO•
and S-nitrosylation of membrane protein thiols. These changes
were shown to be independent on changes in respiration rates, mem-
brane potential and Ca2+ content in the organelle. It is proposed thatS-nitrosylation of critical membrane protein thiols protects against
MPT and thus against mitochondrial damage.
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